04/27/2009
https://www.congress.gov...
"These are exciting times for NIH. After several years of stagnant funding, the Recovery Act has breathed new life into the field of biomedical research."
"I don't want any of you here at the table to take this wrongly, but all of this money won't just go to Bethesda."
"We provided $1.1 billion for comparative effectiveness in the Recovery Act."
"Would you tell us what, if anything, is being done to expand the research portfolio for this lethal form of cancer?"